Literature DB >> 35113154

Waking up CML leukemia stem cells for the kill.

Kaosheng Lv1,2, Wei Tong1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35113154      PMCID： PMC8814681          DOI： 10.1182/blood.2021014629

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  10 in total

1.  Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.

Authors:  Tomohiko Ishibashi; Takafumi Yokota; Yusuke Satoh; Michiko Ichii; Takao Sudo; Yukiko Doi; Tomoaki Ueda; Yasuhiro Nagate; Yuri Hamanaka; Akira Tanimura; Sachiko Ezoe; Hirohiko Shibayama; Kenji Oritani; Yuzuru Kanakura
Journal:  Biochem Biophys Res Commun       Date:  2017-12-22       Impact factor: 3.575

Review 2.  Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.

Authors:  Susan Branford; Dennis Dong Hwan Kim; Jane F Apperley; Christopher A Eide; Satu Mustjoki; S Tiong Ong; Georgios Nteliopoulos; Thomas Ernst; Charles Chuah; Carlo Gambacorti-Passerini; Michael J Mauro; Brian J Druker; Dong-Wook Kim; Francois-Xavier Mahon; Jorge Cortes; Jerry P Radich; Andreas Hochhaus; Timothy P Hughes
Journal:  Leukemia       Date:  2019-06-17       Impact factor: 11.528

3.  Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Authors:  Andreas Hochhaus; Richard A Larson; François Guilhot; Jerald P Radich; Susan Branford; Timothy P Hughes; Michele Baccarani; Michael W Deininger; Francisco Cervantes; Satoko Fujihara; Christine-Elke Ortmann; Hans D Menssen; Hagop Kantarjian; Stephen G O'Brien; Brian J Druker
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

4.  Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells.

Authors:  Zhaoyuan Liu; Yaqi Gu; Svetoslav Chakarov; Camille Bleriot; Immanuel Kwok; Xin Chen; Amanda Shin; Weijie Huang; Regine J Dress; Charles-Antoine Dutertre; Andreas Schlitzer; Jinmiao Chen; Lai Guan Ng; Honglin Wang; Zhiduo Liu; Bing Su; Florent Ginhoux
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

5.  Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.

Authors:  Amie S Corbin; Anupriya Agarwal; Marc Loriaux; Jorge Cortes; Michael W Deininger; Brian J Druker
Journal:  J Clin Invest       Date:  2010-12-13       Impact factor: 14.808

Review 6.  The tetraspan MS4A family in homeostasis, immunity, and disease.

Authors:  Irene Mattiola; Alberto Mantovani; Massimo Locati
Journal:  Trends Immunol       Date:  2021-08-09       Impact factor: 16.687

7.  MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.

Authors:  Helong Zhao; Anthony D Pomicter; Anna M Eiring; Anca Franzini; Jonathan Ahmann; Jae-Yeon Hwang; Anna Senina; Bret Helton; Siddharth Iyer; Dongqing Yan; Jamshid S Khorashad; Matthew S Zabriskie; Anupriya Agarwal; Hannah M Redwine; Amber D Bowler; Phillip M Clair; Shannon K McWeeney; Brian J Druker; Jeffrey W Tyner; Derek L Stirewalt; Vivian G Oehler; Sooryanarayana Varambally; Kristofer C Berrett; Jeffery M Vahrenkamp; Jason Gertz; Katherine E Varley; Jerald P Radich; Michael W Deininger
Journal:  Blood       Date:  2022-02-03       Impact factor: 22.113

Review 8.  Response and Resistance to BCR-ABL1-Targeted Therapies.

Authors:  Theodore P Braun; Christopher A Eide; Brian J Druker
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

9.  Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.

Authors:  Christopher A Eide; Matthew S Zabriskie; Samantha L Savage Stevens; Orlando Antelope; Nadeem A Vellore; Hein Than; Anna Reister Schultz; Phillip Clair; Amber D Bowler; Anthony D Pomicter; Dongqing Yan; Anna V Senina; Wang Qiang; Todd W Kelley; Philippe Szankasi; Michael C Heinrich; Jeffrey W Tyner; Delphine Rea; Jean-Michel Cayuela; Dong-Wook Kim; Cristina E Tognon; Thomas O'Hare; Brian J Druker; Michael W Deininger
Journal:  Cancer Cell       Date:  2019-09-19       Impact factor: 31.743

10.  An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.

Authors:  Tun Kiat Ko; Asif Javed; Kian Leong Lee; Thushangi N Pathiraja; Xingliang Liu; Simeen Malik; Sheila Xinxuan Soh; Xiu Ting Heng; Naoto Takahashi; Joanna H J Tan; Ravi Bhatia; Alexis J Khng; Wee-Joo Chng; Yee Yen Sia; David A Fruman; King Pan Ng; Zhu En Chan; Kim Jiajing Xie; Qiangze Hoi; Cheryl Xueli Chan; Audrey S M Teo; Oscar Velazquez Camacho; Wee Yang Meah; Chiea Chuen Khor; Chin Thing J Ong; Wei Jia W Soon; Patrick Tan; Pauline C Ng; Charles Chuah; Axel M Hillmer; S Tiong Ong
Journal:  Blood       Date:  2020-06-25       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.